Skip to main content
. 2019 Feb 27;9:2973. doi: 10.1038/s41598-018-37777-z

Figure 1.

Figure 1

P. gingivalis LPS and the TLR2 agonist Pam2CSK4 increase the expression of BDKRB1 and BDKRB2 mRNA in human gingival fibroblasts. Time-course of the expression of BDKRB1 and BDKRB2 in human gingival fibroblasts cultured in the presence or absence of 10 μg/mL of P. gingivalis LPS (A,B). P. gingivalis LPS dose dependently increased mRNA expression of BDKRB1 (C) and BDKRB2 (D) in human gingival fibroblasts after 6 h of treatment with LPS. Pam2CSK4 (50 ng/mL) increased BDKRB1 and BDKRB2 mRNA in human gingival fibroblasts after 6 h of treatment (E). Data were normalized against RPL13A and are expressed as percentage of the means for the controls at 3 h (A) or controls (BE), which was arbitrarily set to 100%. Values represent means for 3 wells/experimental group and SEM is shown as vertical bar. * and ** indicate significant difference to untreated control cells, P < 0.05 and P < 0.01, respectively. Statistical significance was determined using Student’s t test (A, B and E) or one-way analysis of variance (ANOVA), with Levene’s homogeneity test and Dunnet’s T3 post hoc test (C,D).